• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 279
      In vivo CAR T cell generation to treat cancer and autoimmune disease - 17 day(s) ago

      Chimeric antigen receptor (CAR) T cell therapies have transformed treatment of B cell malignancies. However, their broader application is limited by complex manufacturing processes and the necessity for lymphodepleting chemotherapy, restricting patient …

      Source: www.science.org
      Categories: General Medicine News, Future of Medicine
      Tweet Tweets with this article
      • Profile photo of 	NatureBiotech
        NatureBiotech

        CD8-targeted lipid nanoparticles carrying anti-CD19 CAR mRNA were developed to generate CAR-T cells directly in vivo, demonstrating effective B cell depletion for potential treatment of B cell malignancies and autoimmune diseases. https://t.co/7wq1PmXQqo #NBThighlight

    • Mashup Score: 267
      In vivo CAR T cell generation to treat cancer and autoimmune disease - 17 day(s) ago

      Chimeric antigen receptor (CAR) T cell therapies have transformed treatment of B cell malignancies. However, their broader application is limited by complex manufacturing processes and the necessity for lymphodepleting chemotherapy, restricting patient …

      Source: www.science.org
      Categories: General Medicine News, Future of Medicine
      Tweet Tweets with this article
      • Profile photo of 	NatureBiotech
        NatureBiotech

        CD8-targeted lipid nanoparticles carrying anti-CD19 CAR mRNA were developed to generate CAR-T cells directly in vivo, demonstrating effective B cell depletion for potential treatment of B cell malignancies and autoimmune diseases. https://t.co/7wq1PmXQqo #NBThighlight

    • Mashup Score: 57
      Pan-viral ORFs discovery using massively parallel ribosome profiling - 17 day(s) ago

      Defining viral proteomes is crucial to understanding viral life cycles and immune recognition but the landscape of translated regions remains unknown for most viruses. We have developed massively parallel ribosome profiling (MPRP) to determine open …

      Source: www.science.org
      Categories: General Medicine News, Future of Medicine
      Tweet Tweets with this article
      • Profile photo of 	NatureBiotech
        NatureBiotech

        Massively parallel ribosome profiling allows the investigation of open reading frames in viral sequences, a tool that could be used to expand the repertoire of vaccine targets https://t.co/URg3hPzsY0 #NBThighlight

    • Mashup Score: 6
      Infant receives the first customized CRISPR therapy - 18 day(s) ago

      Nature Biotechnology – Infant receives the first customized CRISPR therapy

      Source: www.nature.com
      Categories: General Medicine News, Future of Medicine
      Tweet Tweets with this article
      • Profile photo of 	NatureBiotech
        NatureBiotech

        Research Highlight: Infant receives the first customized CRISPR therapy https://t.co/nUor3gJz7u

    • Mashup Score: 24
      Organoid culture promotes dedifferentiation of mouse myoblasts into stem cells capable of complete muscle regeneration - 19 day(s) ago

      Nature Biotechnology – Mouse stem cells that regenerate muscle are derived by organoid dedifferentiation of myoblasts.

      Source: www.nature.com
      Categories: General Medicine News, Future of Medicine
      Tweet Tweets with this article
      • Profile photo of 	NatureBiotech
        NatureBiotech

        Mouse stem cells that regenerate muscle are derived by organoid dedifferentiation of myoblasts https://t.co/5Vjk7vdSvs https://t.co/c2P4aMrB6A

    • Mashup Score: 9
      New tool improves the detection of hidden genetic mutations - 19 day(s) ago

      The tool, described in Nature Biotechnology, will help understand how changes in our DNA affect proteins and ultimately contribute to cancer, neurodegenerative diseases, and other conditions.

      Source: www.uclahealth.org
      Categories: General Medicine News, Future of Medicine
      Tweet Tweets with this article
      • Profile photo of 	NatureBiotech
        NatureBiotech

        @dgsomucla @UCLAHealth @UCLAHealthJCCC @uoftmedicine @PMResearch_UHN @VectorInst @TheBoutrosLab @KislingerThomas @Chenghao_Zhu New tool improves the detection of hidden genetic mutations #NBTIntheNews via @UCLAHealth https://t.co/20AbE1jXXm

    • Mashup Score: 32
      Court reignites CRISPR patent dispute - 19 day(s) ago

      Nature Biotechnology – Court reignites CRISPR patent dispute

      Source: www.nature.com
      Categories: General Medicine News, Future of Medicine
      Tweet Tweets with this article
      • Profile photo of 	NatureBiotech
        NatureBiotech

        In Brief: @UofCalifornia and @univienna convince US appeals court to revive their bid for patent rights to the CRISPR–Cas9 gene-editing technology created by Jennifer Doudna and Emmanuelle Charpentier https://t.co/UfKo06QfkD https://t.co/YhqHPmi5xj

    • Mashup Score: 41
      Rapid generation of functional vascular organoids via simultaneous transcription factor activation of endothelial and mural lineages - 20 day(s) ago

      Melero-Martin and colleagues developed a rapid method to generate vascular organoids from human iPSCs by orthogonally activating the transcription factors ETV2 and NKX3.1. This strategy enabled controlled co-differentiation of vascular cells and supported in vivo engraftment, offering a versatile platform for vascular biology, tissue engineering, and regenerative medicine.

      Source: www.cell.com
      Categories: General Medicine News, Future of Medicine
      Tweet Tweets with this article
      • Profile photo of 	NatureBiotech
        NatureBiotech

        Vascular organoids promote revascularization of ischemic muscle and pancreatic islet transplantation in mice https://t.co/u9p7FC1zZF #NBThighlight

    • Mashup Score: 7
      Go fund a brain gain - 20 day(s) ago

      Nature Biotechnology – The gutting of US research funding represents a once-in-a-generation opportunity for Europe to boost world-class research deprioritized by the Trump administration.

      Source: www.nature.com
      Categories: General Medicine News, Future of Medicine
      Tweet Tweets with this article
      • Profile photo of 	NatureBiotech
        NatureBiotech

        Go fund a brain gain The gutting of US research funding represents a once-in-a-generation opportunity for Europe to boost world-class research deprioritized by the Trump administration https://t.co/wAtf4XIgp6 https://t.co/yEWIwRlGWW

    • Mashup Score: 93
      Identification of non-canonical peptides with moPepGen - 20 day(s) ago

      Nature Biotechnology – moPepGen enables the detection of peptides across species, proteases and technologies.

      Source: www.nature.com
      Categories: General Medicine News, Future of Medicine
      Tweet Tweets with this article
      • Profile photo of 	NatureBiotech
        NatureBiotech

        Identification of non-canonical peptides with moPepGen https://t.co/dibHWrSI7G https://t.co/Yx8n45mIsu

    Load More

    Nature Biotechnology

    @NatureBiotech

    Nature Biotechnology is a monthly journal covering the science and business of biotechnology. Part of @nresearchnews and @SpringerNature.

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings